# Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)

> **NCT01447667** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 72 (actual)

## Conditions studied

- Hepatic Fibrosis
- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Magnetic resonance elastography

## Key facts

- **NCT ID:** NCT01447667
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447667, "Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01447667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*